SEP 11, 2019 10:52 AM PDT

Insulin Drug Could Treat Glioblastoma

WRITTEN BY: Nouran Amin

A molecule used for drug delivery of insulin was recently found by researchers at the University of Georgia’s Regenerative Bioscience Center to hold treatment capabilities for an aggressive and fatal form of brain cancer—glioblastoma.

Glioblastoma is a fast-growing tumor that arises from supportive tissue around the brain that eventually resist any surgical treatment. The tumor cells become challenging to remove when it is surrounded by healthy brain tissue. More than half of all new cases pass away within the first 15 months. However, the death of late U.S. Sens. John McCain and Ted Kennedy have brought national awareness to that particular cancer and more research attention.

Learn more about glioblastoma:

Now, researchers at the University of Georgia (UGA), discovered that ‘surfen’--a compound first introduced in 1938—is a pharmaceutical agent for optimizing insulin delivery. The researchers described that surfen-treated cells did not further the tumor growth or the the spread of tumor cells.

The MRI image shows the effects of the surfen treatment] pretty drastically.The non-treated image indicates see rampant invasive growth in comparison to the surfen-models where you see a contained tumor.”

Image Credit UGA.edu

“This study shows that we can stifle the growth of invasive brain tumors with a compound that has a substantial clinical advantage, and can aid in the reduction or refinement of mainstream treatments, particularly radiation and/or chemo,” said Lohitash Karumbaiah, associate professor of regenerative medicine in UGA’s College of Agricultural and Environmental Sciences.

Findings of the study were reported in the FASEB Journal. It was the first to report the use of surfen as an application for the treatment of glioblastoma.

“In basic terms, surfen is highly positively charged and will bind to negatively charged things,” said Meghan Logun, a graduate student working with Karumbaiah. “Since we study sugars in the brain, which are highly negatively charged, we then asked, ‘Why not try using positive charges to block off the negative ones? In the surfen-treated animals, we saw that the tumors were actually much more constrained and had more defined boundaries.”

From UGA.edu: Lohitash Karumbaiah at work in his lab. (Photo by Dorothy Kozlowski/UGA)

“The tumor may still grow, but at least now it doesn’t have any invasive inroads to creep into other parts of the brain,” said Karumbaiah. “That could be clinically beneficial for a surgeon wanting to remove the tumor and not having to worry about rogue cancer cells. Our hope is that, in the wake of this discovery, lives can be saved, and we can finally change the scope of this life-threatening disease.”

Source: Science Daily

 

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JAN 09, 2020
Drug Discovery & Development
JAN 09, 2020
Can Cancer Drugs Treat Lung Damage?
Can therapeutics used in the treatment of cancer be a breakthrough for pulmonary disease? Specifically, chronic obstructive pulmonary disease (COPD)? &ldqu...
JAN 14, 2020
Drug Discovery & Development
JAN 14, 2020
Can Silica Treat Obesity and Diabetes?
Silica particles, specifically ‘mesoporous silica particles (MSPs)’ are engineered molecular traps that may provide a breakthrough treatment op...
FEB 11, 2020
Cannabis Sciences
FEB 11, 2020
Traffic Light System Best Way to Label Cannabis Edibles
Cannabis products have become increasingly popular. Yet, as they are still relatively new to the market, research has found that most consumers don’t...
MAR 22, 2020
Cancer
MAR 22, 2020
What is "Shotgun ion mobility mass spectrometry sequencing"?
Research published recently in Nature Communications highlights a new method of mapping an essential family of polysaccharides called GAGs (glycosaminoglyc...
MAR 16, 2020
Drug Discovery & Development
MAR 16, 2020
Understanding How an Obesity-Treating Drug Functions
Liraglutide is a drug targeted to help treat obesity by suppressing appetite, thus making the patient lose weight. However, up until now research has not d...
MAR 31, 2020
Cancer
MAR 31, 2020
Ovarian cancer metastasis and CPT1A
Research published in the journal Molecular Cancer Research from collaborators at the University of Colorado Cancer Center hits on new insight as...
Loading Comments...